Wn confirmed that fertility was retained in these mice only from 60 weeks of age (Takehashi et al., 2007), but all occludin knockout mice had been infertile by 360 weeks of age with the tubules devoid of spermatocytes and spermatids (Saitou et al., 2000; Takehashi et al., 2007). Collectively, these findings illustrate that while other TJ proteins, for instance claudins and JAMs, may be able to supersede the loss of occludin at the BTB to preserve spermatogenesis; on the other hand, occluding is absolutely essential to retain the BTB function and spermatogenesis beyond 10 weeks of age in rodents in the course of adulthood, illustrating the functional partnership amongst BTB and maintenance of spermatogenesis. Interestingly, the necessity of occludin to spermatogenesis doesn’t apply to humans as occludin was not identified in human Sertoli cells in an earlier study (Moroi et al., 1998). Having said that, a current study by RT-PCR has identified occludin in human Sertoli cells (Xiao and Cheng, unpublished observations), illustrating further study around the function of occludin in huamn BTB is warranted. The lack of occludin in human seminiferous epithelium also illustrates that the BTB is actually a complicated ultrastructure and its constituency is species-specific. Other research have also shown that the role of occludin in blood challenge barriers is organand/or tissue-specific. As an illustration, occludin isn’t critical for the formation of TJ strands; and in some cell forms, it’s not even needed for the upkeep of TJs. It was reported that occludin was not found within the TJ strands among porcine aortic endothelial cells (Hirase et al., 1997), revealing that in some tissues, occludin is not a constituent protein from the TJ barrier. Furthermore, in occludin knockout mice, the TJ barrier formed between intestinal epithelial cells was indistinguishable from those of the wild sort ultrastructurally (Saitou et al., 2000), demonstrating that in some epithelia that commonly express occludin, a missing of occludin does not necessarily influence the formation and/or maintenance of your TJ barrier. Moreover, while studies have shown that treatment of synthetic occludin peptide disrupted TJ barrier in between Sertoli cells (Chung et al., 2001) also as that in between intestinal epithelial cells (Nusrat et al., 2005), a study in human intestinal T84 HD2 medchemexpress epithelialNIH-PA Author Manuscript NIH-PA Author Manuscript NIH-PA Author ManuscriptInt Rev Cell Mol Biol. Author manuscript; offered in PMC 2014 July 08.Mok et al.Web page(T84) cell cultures has shown that the occludin peptide-induced TJ-barrier disruption was mediated by redistribution of other TJ proteins (e.g. claudin-1) and TJ adaptor (e.g. ZO-1) (Nusrat et al., 2005), illustrating occludin may act as a “signaling” regulatory TJ protein. Much more essential, the usage of monoclonal COX Gene ID antibody against the second extracellular loop of occludin in T84 cells was located to disrupt epithelial cell polarity but not the TJ barrier (Tokunaga et al., 2007). Collectively, these findings illustrate the complicated functional function of occludin at the TJ barrier, supporting the notion of its species- and/or tissue-specific function regarding its involvement in TJ-barrier formation and maintenance. Nonetheless, these findings illustrate that occludin, in contrast to claudins, may well have other function(s) and serving as a signaling molecule in controlling the permeability in TJs, such as fine-tuning the barrier function, besides serving as the building block of TJs in some epithelia. This notion is also s.
bet-bromodomain.com
BET Bromodomain Inhibitor